The
Tasty&Healthy study
Inclusion criteria
ACTIVE-RCT-I
ACTIVE-RCT-II
Mild-moderate disease activity (wPCDAI 20-57.5 or CDAI 200-450) or milder disease (wPCDAI 12.5-57.5 or CDAI 150-450)
Clinical remission or at most minimal symptoms (wPCDAI<20/ CDAI<200)
Ages 6-24
Ages 6-40
Disease duration: less than a year
Disease duration <3 years 

MINI≥8 points (FC>600 OR FC>300 and elevated CRP/ESR)
No drugs or maintenance stable treatment IMM/5ASA
No drugs or maintenance stable treatment IMM/5ASA or first biologic
Exclusion criteria for both trials
  • Fibrostenotic or penetrating phenotype
  • Fistulizing perianal disease which is not in complete remission.
  • UC-like” isolated Crohn’s colitis.
  • Prior failure of exclusive enteral nutrition or any other dietary intervention, for any reason.
  • The use of steroids, budesonide or antibiotics prescribed to treat the CD in the recent month.
  • Any formula feed during the last month.
  • Prior intestinal resection.
  • Pregnancy.
  • Celiac disease.
  • For ACTIVE-RCT-I: any prior or concurrent biologic therapy; for MH-RCT-II: any prior or concurrent biologic therapy other than one first biologic.
Contact us
Study PI: Prof. Dan Turner | [email protected] 
Study Management: Gili Focht | [email protected]  | Luba Plotkin | [email protected] 
Tamar Nave| [email protected]  | Yonat Aharoni | [email protected]
FacebookInstagram/WhatsappWebsite